CAS: 113-52-0; 3-(10,11-Dihydro-5H-Dibenzo[b,F]Azepin-5-yl)-N,N-Dimethylpropan-1-Amine Hydrochloride

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号494-19-9 亚氨基二苄 | CAS号6829-98-7 氧丙咪嗪 | CAS号50-47-5 盐酸去甲咪嗪 | CAS号796-28-1 10-hydroxyimipramine | CAS号303-70-8 11-[3-(dimethyl... | CAS号10075-24-8 米帕明双羟萘酸盐 | CAS号61361-33-9 盐酸丙咪嗪-D4

合成工艺路线路线简述

    📜米帕明,盐酸 以80%的收率获得
    参考文献:Vasilioni,Virgil-Gheorghe;Matei,Simion Laurentiu;Persa,Maria;Breazu,D+
    标题:Vasilioni,Virgil-Gheorghe;Matei,Simion Laurentiu;Persa,Maria;Breazu,D+

    海关参考信息

    专利信息


    专利号:US-5578500-A
    优先权日:1991-07-31
    标 题 :Reagents and methods for the quantification of imipramine or desipramine in biological fluids
    发明人:ADAMCZYK MACIEJ; HARRINGTON CHARLES A; JOHNSON DONALD
    权利人:ABBOTT LAB
    摘要:Immunoassay methods and reagents for the specific quantification of imipramine or desipramine in a test sample are disclosed. The measurement of imipramine or desipramine is accomplished in a specific immunoassay employing antibodies prepared with imipramine or desipramine derivatives of the Formula III: ##STR1## wherein P is an immunogenic carrier material, X is two heteroatoms, Y is a linking group comprising from 1 to 6 carbon atoms and P is an immunogenic carrier material, and wherein for imipramine, R is CH 3 , and for desipramine, R is H. n The present invention also describes the synthesis of unique labeled reagents of the structure of the Formula IV: ##STR2## wherein Z is a linking group comprising 1 to 4 carbon atoms and 0 to 2 heteroatoms and Q is a detectable moiety, preferably fluorescein or a fluorescein derivative, and wherein for imipramine, R 1 is CH 3 , and for desipramine, R 1 is H.

    专利号:US-5614419-A
    优先权日:1991-07-31
    标 题 :Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids
    发明人:ADAMCZYK MACIEJ; FISHPAUGH JEFFREY R; JOHNSON DONALD; HARTTER DARYL E
    权利人:ABBOTT LAB
    摘要:Immunoassay methods and reagents for the specific quantification of amitriptyline or nortriptyline in a test sample are disclosed employing antibodies prepared with amitriptyline or nortriptyline derivatives of the Formula III: ##STR1## wherein for amitriptyline, R is CH 3 , and for nortriptyline, R is H. The present invention also describes the synthesis of unique fluorescein tracers of the structure of Formula IV and Formula V: ##STR2## wherein for a specific amitriptyline immunoassay, W 1 is a heteroatom linked to the aromatic ring at the 2 or 3 position, and for a specific nortriptyline immunoassay, W 2 is two heteroatoms linked together and attached to the aromatic ring at the 2 or 3 position, and wherein Q is a detectable moiety, preferably fluorescein or a fluorescein derivative.

    专利号:US-9751877-B2
    优先权日:2012-09-21
    标题 :Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
    发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; PATEL NANDINI CHATURBHAI; STIFF CORY MICHAEL; TRAN TUAN PHONG; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:WO-2012172449-A1
    优先权日:2011-06-13
    标题:Lactams as beta secretase inhibitors
    发明人:BRODNEY MICHAEL AARON
    权利人:PFIZER; BRODNEY MICHAEL AARON
    摘要:Compound and pharmaceutically acceptable salts of the compound are disclosed, wherein the compound has the structure (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. The compound of formula I is useful as beta secretase inhibitor for use in the treatment of Alzheimer's and other neurodegenerative and/or neurological disorders.

    专利号:US-2016229847-A1
    优先权日:2013-10-04
    标 题:Novel bicyclic pyridinones as gamma-secretase modulators
    发明人:PETTERSSON MARTIN YOUNGJIN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; JOHNSON DOUGLAS SCOTT; KAUFFMAN GREGORY WAYNE; O'DONNELL CHRISTOPHER WILLIAM; PATEL NANDINI CHATURBHAI; STEPAN ANTONIA FRIEDERIKE; STIFF CORY MICHAEL; SUBRAMANYAM CHAKRAPANI; TRAN TUAN PHONG; VERHOEST PATRICK ROBERT
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula II as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-9067934-B2
    优先权日:2011-03-31
    标题 :Bicyclic pyridinones
    发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; FISH BENJAMIN ADAM; GREEN MICHAEL ERIC; MULLINS PATRICK BRADLEY; STIFF CORY MICHAEL; TRAN TUAN PHONG; NAVARATNAM THAYALAN
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Hearn L, Derry S, Phillips T, Moore RA, Wiffen PJ. Imipramine for neuropathic pain in adults. Cochrane Database Syst Rev. 2014 May 19;5:CD010769. doi: 10.1002/14651858.CD010769.pub2. Review. doi: 10.1111/j.1600-0560.2008.01121.x. Review. Review. Review. Review. Review. Japanese. Review. Review. Review. Review. Review. Review. Review. Review. Review. Review. Review. Review. Review. Review.

    合成参考文献


    摘要:Archives Internationales de Pharmacodynamie et de Therapie., 137(375), 1962 []
    摘要:British Medical Journal., 2(1458), 1959
    摘要:Arzneimittel-Forschung. Drug Research., 31(75), 1981 []
    摘要:JAMA, Journal of the American Medical Association., 230(1405), 1974 []
    摘要:Arzneimittel-Forschung. Drug Research., 24(166), 1974 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知